Apnimed, Inc.
Status: Publicly traded
Direct answer
Apnimed, Inc. is publicly traded on NASDAQ under the ticker APMD.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge,...
Can you invest in Apnimed, Inc.?
Yes. Apnimed, Inc. trades publicly on NASDAQ as APMD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Apnimed, Inc.
Detailed equity research is provided by MarketSnap.